NVIV

InVivo Therapeutics Holdings Corp
NVIV

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

16 hedge funds and large institutions have $706K invested in InVivo Therapeutics Holdings Corp in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$119K
2
+$119K
3
+$73K
4
Two Sigma Investments
Two Sigma Investments
New York
+$49K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$45K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$184K
2
$149K
3
$119K
4
$73K
5
$49K
6
$47K
7
$45K
8
$24K
9
$7K
10
$6K
11
$2K
12
$1K